ALS-002200
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ALS-002200, covering 2017-10-31 to 2017-10-31. Get the full timeline:
Most recent: Clinical Trial Update: First in Human Study of ALS-002200; Single Dose, Food Effect in Healthy Volunteers; Multiple Doses in Chronic Hepatitis C Genotype 1 [Phase 1]